CIGNA Co. (CI) Shares Bought by Steward Partners Investment Advisory LLC

Share on StockTwits

Steward Partners Investment Advisory LLC lifted its stake in CIGNA Co. (NYSE:CI) by 8.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 3,662 shares of the health services provider’s stock after buying an additional 292 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in CIGNA were worth $763,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Handelsbanken Fonder AB lifted its position in CIGNA by 103.8% during the 3rd quarter. Handelsbanken Fonder AB now owns 2,568 shares of the health services provider’s stock valued at $535,000 after acquiring an additional 1,308 shares during the period. Welch Capital Partners LLC NY purchased a new position in CIGNA during the 3rd quarter valued at about $378,000. Meag Munich Ergo Kapitalanlagegesellschaft MBH lifted its position in CIGNA by 56.7% during the 3rd quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 34,211 shares of the health services provider’s stock valued at $7,022,000 after acquiring an additional 12,372 shares during the period. Calamos Advisors LLC lifted its position in CIGNA by 68.6% during the 3rd quarter. Calamos Advisors LLC now owns 38,632 shares of the health services provider’s stock valued at $8,045,000 after acquiring an additional 15,719 shares during the period. Finally, IFM Investors Pty Ltd lifted its position in CIGNA by 16.0% during the 3rd quarter. IFM Investors Pty Ltd now owns 12,788 shares of the health services provider’s stock valued at $2,663,000 after acquiring an additional 1,768 shares during the period. 89.08% of the stock is owned by hedge funds and other institutional investors.

In other news, Director William D. Zollars sold 238 shares of CIGNA stock in a transaction that occurred on Friday, September 14th. The shares were sold at an average price of $193.70, for a total value of $46,100.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.10% of the company’s stock.

A number of analysts have weighed in on the stock. SunTrust Banks raised their price objective on shares of CIGNA and gave the company a “buy” rating in a research note on Thursday, September 27th. Zacks Investment Research upgraded shares of CIGNA from a “hold” rating to a “buy” rating and set a $212.00 price objective for the company in a research note on Tuesday, August 7th. Jefferies Financial Group restated a “buy” rating and set a $224.00 price objective on shares of CIGNA in a research note on Friday, August 3rd. ValuEngine upgraded shares of CIGNA from a “sell” rating to a “hold” rating in a research note on Friday, August 3rd. Finally, Leerink Swann raised their price objective on shares of CIGNA from $235.00 to $250.00 and gave the company an “outperform” rating in a research note on Friday, September 21st. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $231.14.

NYSE:CI opened at $206.87 on Tuesday. The stock has a market cap of $50.30 billion, a price-to-earnings ratio of 19.78, a PEG ratio of 1.22 and a beta of 0.64. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.38 and a quick ratio of 0.38. CIGNA Co. has a fifty-two week low of $163.02 and a fifty-two week high of $227.13.

CIGNA (NYSE:CI) last announced its quarterly earnings results on Thursday, August 2nd. The health services provider reported $3.89 EPS for the quarter, topping analysts’ consensus estimates of $3.33 by $0.56. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. The firm had revenue of $11.50 billion during the quarter, compared to analyst estimates of $11.20 billion. During the same period in the previous year, the business posted $2.91 earnings per share. The business’s revenue for the quarter was up 10.9% on a year-over-year basis. Equities research analysts expect that CIGNA Co. will post 13.87 earnings per share for the current year.

CIGNA Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply